| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8223353 | International Journal of Radiation Oncology*Biology*Physics | 2013 | 9 Pages |
Abstract
IMRT can reduce dose to BM subregions identified by 18F-fluorodeoxyglucose-PET/CT and IDEAL IQ. The efficacy of BM-sparing IMRT is being tested in a phase II trial.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Yun PhD, Mark PhD, Catheryn M. MD, Brent S. MD, Mariel CMD, Carl K. MD, Joshua D. MD, John MD, Cheryl MD, Paul MD, Arno J. MD, Graeme M. MD, Loren K. MD,